Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
VSee Health ( (VSEE) ) has shared an announcement.
On October 20, 2025, VSee Health, Inc. entered into a note purchase agreement with an accredited institutional investor, issuing a secured note worth $133,333.33 at a purchase price of $120,000. The note, which bears a 5% annual interest rate and matures on May 20, 2026, includes standard default provisions and restrictions on variable rate transactions and exchange transactions involving the company’s debt or securities. Additionally, on the same date, VSee Health amended previous security agreements to ensure the note is fully secured by the company’s assets. On October 18, 2025, the company terminated an Equity Purchase Agreement from November 21, 2023, with another accredited institutional investor.
The most recent analyst rating on (VSEE) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.
VSee Health’s overall stock score is heavily impacted by financial instability and the risk of Nasdaq delisting. While there is some revenue growth, the negative equity, poor valuation, and bearish technical indicators contribute to a low score.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
Average Trading Volume: 969,001
Technical Sentiment Signal: Sell
Current Market Cap: $8.12M
For a thorough assessment of VSEE stock, go to TipRanks’ Stock Analysis page.